Nicotinell Mint (Nicotine Bitartrate Dihydrate)

Nicotine Bitartrate Dihydrate, the active ingredient in Nicotinell Mint, is a nicotine replacement therapy presented as an oral lozenge for oromucosal use. It helps adult smokers manage nicotine withdrawal symptoms during a quit attempt.

GNH USA supplies Nicotinell Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for bulk and small‑scale orders. All shipments are accompanied by full regulatory documentation to facilitate import clearance. Customer support is available 24/7 for technical queries. Products are packaged in tamper‑evident containers.

Nicotinell Mint, a nicotine replacement therapy, is used to support smokers who wish to quit by reducing nicotine cravings and withdrawal.

- Smoking cessation: assists adult smokers in gradually reducing nicotine dependence and managing withdrawal symptoms. - Tobacco dependence: provides a controlled nicotine dose to replace cigarettes during the quitting process. - Nicotine withdrawal: alleviates cravings, irritability, and concentration difficulties associated with abrupt cessation.

Nicotinell Mint may cause a range of oral and systemic reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness: mild discomfort at the site of lozenge placement. - Nausea or upset stomach: transient digestive upset after lozenge use. - Hiccups or increased salivation: stimulation of oral mucosa may trigger these responses. - Heartburn or dyspepsia: occasional acid reflux symptoms.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention. - Chest pain or palpitations: may indicate cardiovascular stress and should be evaluated promptly. - Severe nausea, vomiting, or dizziness: persistent symptoms that interfere with daily activities.

When considering Nicotinell Mint, healthcare providers should evaluate the following precautions to ensure safe use.

- Cardiovascular assessment: avoid use in patients with recent myocardial infarction or unstable angina. - Blood pressure monitoring: caution in individuals with uncontrolled hypertension. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Drug interactions: review concomitant medications that may be affected by nicotine metabolism. - Children: keep out of reach of children to prevent accidental ingestion. - Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and direct sunlight.

Nicotine can influence the pharmacokinetics of several medicines; the following interactions are recognised.

Major Interactions (Avoid): - Theophylline: nicotine induces CYP1A2, increasing clearance and reducing therapeutic effect. - Clozapine: enhanced metabolism may lower plasma concentrations, risking loss of efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: nicotine may alter INR; monitor coagulation parameters regularly. - Insulin or oral hypoglycemics: nicotine can affect glucose control; adjust dosage as needed. - Beta‑blockers: nicotine‑induced tachycardia may be masked, requiring careful cardiovascular monitoring.